Update on esophagitis: Controversial and underdiagnosed causes

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 7, 2009, Pages 1087-1095

  Noffsinger, Amy E ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALPRENOLOL; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; CLOXACILLIN; DIPHENHYDRAMINE; DOXYCYCLINE; ERYTHROMYCIN; IBUPROFEN; INDOMETACIN; LINCOMYCIN; MEFENAMIC ACID; MINOCYCLINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PIROXICAM; POTASSIUM CHLORIDE; SULINDAC; TETRACYCLINE; TINIDAZOLE; TOLMETIN; UNINDEXED DRUG;

ABDOMINAL PAIN; ATOPY; CANCER CHEMOTHERAPY; CARDIA; CARDITIS; CELL INFILTRATION; CELL SWELLING; CHILDHOOD DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG WITHDRAWAL; EDEMA; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; EPITHELIUM HYPERPLASIA; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS PH; ESOPHAGUS STRICTURE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; INTRACARDIAC THROMBOSIS; JOINT DEGENERATION; LYMPHOCYTIC INFILTRATION; MEDLINE; MICROSCOPY; MYCOSIS; NEOPLASM; NEUTROPHIL CHEMOTAXIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PLASMA CELL; REFLUX ESOPHAGITIS; REVIEW; RHEUMATOID ARTHRITIS; SEX RATIO; SQUAMOUS EPITHELIUM; STOMACH ANTRUM VASCULAR ECTASIA; THROMBOSIS; VIRUS INFECTION; VOMITING;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; EOSINOPHILS; ESOPHAGITIS; ESOPHAGITIS, PEPTIC; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 67649817285     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. McDougall NI, Johnston BT, Collins JS, McFarland RJ, Love AH. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. Eur J Gastroenterol Hepatol. 1997;9:1161-1167. (Pubitemid 28039698)
2. van Herwaarden MA, Samsom M, Smout AJ. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology. 2000;119:1439-1446. (Pubitemid 32198668)
3. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327-333. (Pubitemid 28414912)
4. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis" and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol. 1996; 20:S31-S51. (Pubitemid 26274913)
5. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med. 1999;72:81-92. (Pubitemid 30215107)
6. Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98(suppl):S2-S7. (Pubitemid 36348509)
7. Mattox HE 3rd, Richter JE. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med. 1990;89:345-356. (Pubitemid 20323262)
8. Vantrappen G, Janssens J. Gastro-oesophageal reflux disease, an important cause of angina-like chest pain. Scand J Gastroenterol. 1989;24:73-79. (Pubitemid 19279184)
9. Sontag SJ. Gastroesophageal reflux and asthma. Am J Med. 1997;103:84S-90S. (Pubitemid 28020891)
10. Smout AJ. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther. 1997;11(suppl):81-85. (Pubitemid 27520865)
11. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000;61:6-13. (Pubitemid 30098953)
12. Vandenplas Y, Belli D, Benhamou PH, et al. Current concepts and issues in the management of regurgitation in infants: a reappraisal: management guidelines from a working party. Acta Paediatr. 1996;85:531-534. (Pubitemid 126435565)
13. Davidson GP, Omari TI. Reflux in children. Bailliere's Best Pract Res Clin Gastroenterol. 2000;14:839-855. (Pubitemid 30791852)
14. Collins BJ, Elliott H, Sloan JM, McFarland RJ, Love AH. Oesophageal histology in reflux oesophagitis. J Clin Pathol. 1985;38:1265-1272. (Pubitemid 16215042)
15. Geboes K, Desmet V, Vantrappen G, Mebis J. Vascular changes in the esophageal mucosa: an early histologic sign of esophagitis. Gastrointest Endosc. 1980;80:29-32. (Pubitemid 10124202)
16. Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol. 2008;130:508-513.
17. Mangano MM, Antonioli DA, Schnitt SJ, Wang HH. Nature and significance of cells with irregular nuclear contours in esophageal mucosal biopsies. Mod Pathol. 1992;5:191-196.
18. Brown LF, Goldman H, Antonioli DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol. 1984;8:899-905. (Pubitemid 15161465)
19. Lee RG. Marked eosinophilia in esophageal mucosal biopsies. Am J Surg Pathol. 1985;9:475-479. (Pubitemid 16194095)
20. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818-823. (Pubitemid 12060519)
21. Singh SP, Odze RD. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases. Am J Surg Pathol. 1998;22:93-99. (Pubitemid 28016757)
22. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol. 2000;95:1422-1430. (Pubitemid 30396298)
23. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10 year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-1206. (Pubitemid 41797671)
24. Sant'anna AM, Rolland S, Fournet JC, Yazbeck S, Drouin E. Eosinophilic esophagitis in children: symptoms, histology and pH probe results. J Pediatr Gastroenterol Nutr. 2004;39:373-377.
25. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18:211-217. (Pubitemid 43361608)
26. Kerlin P, Jones D, Remedios M, Campbell C. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007;41:356-361. (Pubitemid 46573061)
27. Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004; 59:355-361. (Pubitemid 38337841)
28. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795-801. (Pubitemid 40779406)
29. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940-941. (Pubitemid 39096927)
30. Staumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115:418-419. (Pubitemid 40215113)
31. Walsh SV, Antonioli DA, Goldman H, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol. 1999;23:390-396. (Pubitemid 29159999)
32. Pentiuk SP, Miller CK, Kaul A. Eosinophilic esophagitis in infants and toddlers. Dysphagia. 2007;22:1-5. (Pubitemid 46208202)
33. Assa'ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8 year follow up. J Allergy Clin Immunol. 2007;119:731-738. (Pubitemid 46335818)
34. Byrne KR, Panagiotakis PH, Hilden K, Thomas KL, Peterson KA, Fang JC. Retrospective analysis of esophageal food impaction: differences in etiology by age and gender. Dig Dis Sci. 2006;52:717-721.
35. Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus. 2007;20:311-319. (Pubitemid 47054761)
36. Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol. 2007;41:252-256. (Pubitemid 46340745)
37. Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics and therapy. J Allergy Clin Immunol. 2006;118:1054-1059. (Pubitemid 44666983)
38. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313-319. (Pubitemid 44233586)
39. Ooi CY, Day AS, Jackson R, Bohane TD, Tobias V, Lemberg DA. Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol. 2007; 23:1144-1148.
40. Quaglietta L, Coccorullo P, Miele E, Pascarella F, Troncone R, Staiano A. Eosinophilic oesophagitis and coeliac disease: is there an association? Aliment Pharmacol Ther. 2007;26:487-493. (Pubitemid 47063151)
41. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc. 2002;56:260-270.
42. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004;113:11-28. (Pubitemid 38096157)
43. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006; 116:536-547. (Pubitemid 43228372)
44. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HY. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660-1669. (Pubitemid 37500430)
45. Siafakas CG, Ryan CK, Brown MR, Miller TL. Multiple esophageal rings: an association with eosinophilic esophagitis. Am J Gastroenterol. 2000;95:1572-1575.
46. Vasilopoulos S, Murphy P, Auerbach A. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc. 2002;55:99-106. (Pubitemid 41122937)
47. Rothenberg ME, Mishra A, Collins MH, Putnam PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol. 2001;108:891-894. (Pubitemid 33151538)
48. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-1363.
49. Ruchelli E, Wenner W, Voytek T, Brown K, Liacouras C. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol. 1999;2:15-18. (Pubitemid 29173004)
50. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008;103:435-442. (Pubitemid 351248715)
51. Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus: peptic or allergic eosinophilic esophagitis?: case series of three patients with esophageal eosinophilia. Aliment Pharmacol Ther. 2006;101:1666-1670. (Pubitemid 43980644)
52. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301-1306. (Pubitemid 46802025)
53. Cheng L, Harnett KM, Cao W, et al. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. Gastroenterology. 2005;129: 1675-1685. (Pubitemid 41597406)
54. Farre R, Auli M, Lecea B, Martinez E, Clave P. Pharmacologic characterization of intrinsic mechanisms controlling tone and relaxation of porcine lower esophageal sphincter. J Pharmacol Exp Ther. 2006;316:1238-1248. (Pubitemid 43345299)
55. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503-1512.
56. Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90-93. (Pubitemid 28293032)
57. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998;26:380-385. (Pubitemid 28160684)
58. Seidner DL, Roberts IM, Smith MS. Esophageal obstruction after ingestion of a fiber-containing diet pill. Gastroenterology. 1990;99:1820-1822.
59. Kikendall JW. Pill esophagitis. J Clin Gastroenterol. 1999;28:298-305. (Pubitemid 29246403)
60. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1985;28:686-692. (Pubitemid 15059080)
61. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal antiinflammatory drugs: report of four cases and review of the literature. Arch Intern Med. 1992;152:625-632.
62. Hayllar J, Smith T, Macpherson A, Price AB, Gumpel M, Bjarnason I. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum. 1994;37:1146-1150. (Pubitemid 24313313)
63. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastro-intestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520-1528. (Pubitemid 30844348)
64. Gardner G, Furst DE. Disease-modifying antirheumatic drugs: potential effects in older patients. Drugs Aging. 1995;7:420-437.
65. Semble EL,Wu WC, Castell DO. Nonsteroidal antiinflammatory drugs and esophageal injury. Semin Arthritis Rheum. 1989;19:99-109. (Pubitemid 19269475)
66. Mason JC. NSAIDs and the oesophagus. Eur J Gastroenterol Hepatol. 1999; 11:369-373. (Pubitemid 29199835)
67. Anilkumar TV, Sarraf CE, Hunt T, Alison MR. The nature of cytotoxic druginduced cell death in murine intestinal crypts. Br J Cancer. 1992;65:522-528.
68. Aki S, Eskiyurt N, Akarirmak U, et al. Turkish Osteoporosis Society: gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis. Yonsei Med J. 2003;44:961-967. (Pubitemid 38081560)
69. Graham DY, Malaty HM. Alendronate gastric ulcers. Aliment Pharmacol Ther. 1999;13:515-519. (Pubitemid 29176876)
70. Lanza FL, Evans DG, Graham DY. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol. 1991;86:735-737.
71. Lanza FL, Graham DY, Davis RE, Rack MF. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury: effect of scoring method. Dig Dis Sci. 1990;35:1494-1499.
72. Liberman UI, Hirsch LJ. Esophagitis and alendronate. N Engl J Med. 1996; 335:1069-1070. (Pubitemid 26338744)
73. Lilley LL, Guanci R. Avoiding alendronate-related esophageal irritation. Am J Nursing. 1997;97:12-14. (Pubitemid 127458224)
74. Bauer DC, Black D, Ensrud K, et al. Upper gastrointestinal tract safety profile of alendronate. Arch Intern Med. 2000;160:517-525.
75. de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016-1021. (Pubitemid 26338731)
76. Freiman J, Fitzsimmons SC. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centres in the US. J Pediatr Gastroenterol Nutr. 1996;22:153-156. (Pubitemid 26065986)
77. Abraham SC, Cruz-Correa M, Lee LA, Yardley JH, Wu TT. Alendronateassociated esophageal injury: pathologic and endoscopic features. Mod Pathol. 1999;12:1152-1157. (Pubitemid 30033550)